Daniel Arumi Selected Research

Constipation

2/2019	Do patient characteristics predict which patients with overactive bladder benefit from a higher fesoterodine dose?
6/2015	Fesoterodine clinical efficacy and safety for the treatment of overactive bladder in relation to patient profiles: a systematic review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Arumi Research Topics

Disease

9	Overactive Urinary Bladder (Overactive Bladder) 02/2019 - 05/2011
3	Urinary Incontinence 02/2019 - 02/2015
2	Atopic Dermatitis (Atopic Eczema) 01/2024 - 01/2022
2	Constipation 02/2019 - 06/2015
1	Pain (Aches) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Venous Thromboembolism 01/2022
1	Urge Urinary Incontinence (Urge Incontinence) 06/2015
1	Urinary Retention 02/2015
1	Urinary Tract Infections (Urinary Tract Infection) 05/2011
1	Infections 05/2011

Drug/Important Bio-Agent (IBA)

8	fesoterodine FDA Link 02/2019 - 05/2011
5	Muscarinic AntagonistsIBA 10/2017 - 05/2011
1	abrocitinibIBA 01/2024
1	Factor Xa InhibitorsIBA 01/2022
1	apixabanIBA 01/2022
1	edoxabanIBA 01/2022
1	RivaroxabanIBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2022
1	Phosphodiesterase 4 InhibitorsIBA 01/2022
1	Calcineurin InhibitorsIBA 01/2022
1	Tolterodine Tartrate (Detrol)FDA Link 10/2017

Therapy/Procedure

1	Polypharmacy 01/2017
1	Therapeutics 06/2015
1	Incontinence Pads 05/2011
1	Home Nursing (Nursing, Home) 05/2011